Bladder cancer breakthrough? injection during surgery may slash recurrence
NCT ID NCT07198451
First seen Nov 01, 2025 · Last updated May 23, 2026 · Updated 36 times
Summary
This study tests whether injecting the chemotherapy drug gemcitabine directly into the bladder wall during tumor removal surgery can prevent intermediate- and high-risk bladder cancer from returning. About 320 adults aged 18 to 80 will be randomly assigned to receive either standard care or the additional injection. The main goal is to see if this new approach lowers the chance of cancer coming back within two years.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON-MUSCLE INVASIVE BLADDER CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.